No Data
Zhejiang Gongdong Medical Technology (605369.SH): Plans to launch the first phase of its employee stock ownership plan.
Gelonghui, December 11丨 Zhejiang Gongdong Medical Technology (605369.SH) announced the first phase of its employee stock ownership plan, which, after being reviewed and approved by the company's shareholders' meeting, will acquire and Hold the company's shares held in the company's repurchase special securities Account through non-transaction transfers and other methods permitted by laws and regulations, totaling no more than 1 million shares, accounting for 0.63% of the company's current total share capital. Among them, the initial transfer will be 892,600 shares, accounting for 89.26% of the total number of stocks in this employee stock ownership plan; reserving 107,400 shares, accounting for 10.74% of the total number of stocks in this employee stock ownership plan.
Zhejiang Gongdong Medical Technology (605369.SH): Completed the renewal of the medical instruments production license.
Great Wisdom Report, November 13th | Zhejiang Gongdong Medical Technology (605369.SH) announced that it has recently obtained the "Medical Instruments Production License" reissued by the Zhejiang Provincial Drug Administration, this change is an extension of the license period. The extension of the "Medical Instruments Production License" this time is based on the business needs of the company.
Gongdong Healthcare: Third Quarter Report 2024
Zhejiang Gongdong Medical Technology (605369.SH): The net income for the first three quarters was 0.141 billion yuan, a year-on-year increase of 60.22%.
Gongdong Medical Technology (605369.SH) released the third quarter report for 2024 on October 29. The company's revenue for the first three quarters of the year was 0.836 billion yuan, a year-on-year increase of 17.31%; the net income attributable to shareholders of listed companies was 0.141 billion yuan, a year-on-year increase of 60.22%; the basic earnings per share was 0.90 yuan.
Zhejiang Gongdong Medical Technology (605369.SH) released its performance for the first three quarters, with a net income of 0.141 billion yuan, a year-on-year increase of 60.22%.
Zhejiang Gongdong Medical Technology (605369.SH) released the third quarter report for 2024, during the reporting period the company achieved revenue...
Zhejiang Gongdong Medical Technology (605369.SH) plans to distribute 3 yuan per 10 shares in the interim, with ex-rights and ex-dividends on October 22nd.
Zhejiang Gongdong Medical Technology (605369.SH) announced that the company plans to distribute 1 share for every 10 shares to all shareholders for the first half of 2024.
Here's What's Concerning About Zhejiang Gongdong Medical Technology's (SHSE:605369) Returns On Capital
No Data
